Option Care Health, Inc.

Option Care Health, Inc. provides home and alternate site infusion services across the United States. The company offers a wide range of infusion therapies, including anti-infective therapy, heart failure treatment, home parenteral nutrition, and enteral nutrition support for conditions like stroke, cancer, and gastrointestinal diseases. It also provides immunoglobulin infusion therapies for immune deficiencies, treatments for chronic inflammatory disorders such as Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis, as well as therapies for neurological disorders like Duchenne muscular dystrophy, multiple sclerosis, and Alzheimer's disease. Additionally, Option Care Health offers infusion therapies for bleeding disorders (hemophilia and von Willebrand disease), high-risk pregnancy management, pain management, chemotherapy, and respiratory medications, along with nursing services.

Option Care Health, Inc. is listed on the Nasdaq Global Select Market (NasdaqGS) under the ticker symbol OPCH. The company's financials are reported in US Dollars (USD), reflecting its operations based in the United States.

Option Care Health operates in the Healthcare sector and is classified under the Medical Care Facilities industry. This means the company is involved in providing medical care services, specifically through home and alternate site infusion services, rather than manufacturing pharmaceuticals or medical devices.

Option Care Health is headquartered in Bannockburn, Illinois, United States. The company serves patients across the United States through its home and alternate site infusion services, marketing its offerings via patient referrals from physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations.